Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ANVS

Recent news which mentions ANVS

< Previous 1 2 3 Next >
Annovis Shares Gain As Late-Stage Parkinson's Disease Study Takes-off
Tickers ANVS
Tags Market News Movers & Shakers Patient Enrollment
From Benzinga
Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron
Tickers ANVS LGVN LLY TECH
Tags LLY Tech News
From Benzinga
Dear AMC Stock Fans, Mark Your Calendars for Aug. 4
Tickers AMC ANVS GME VIVO
Tags Market News VIVO GME
From InvestorPlace
Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update
Tickers ANVS GME
Tags Market News Today's Market GME
From InvestorPlace
FDA Gives Green Signal To Annovis Bio's Parkinson's Trial With Buntanetap
Tickers ANVS
Tags Trading Ideas Health Care News
From Benzinga
Annovis Bio Gets FDA Nod For Late-Stage Parkinson Disease Study Amendments
Tickers ANVS
Tags ANVS Biotech Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tickers ACRX ALNA ANVS AVRO
Tags Benzinga Movers ALNA
From Benzinga
83 Biggest Movers From Yesterday
Tickers ACLX ADTH AERC AMLX
Tags GOTU BJDX ATHX
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Tickers ACLX ACRX AERC ANVS
Tags KPRX MVST News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
Tickers ACCD AJG ANVS ARTA
Tags GTYH STTK CMA
From Benzinga
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
Tickers ABBV ALDX ANVS AZN
Tags BMY MRK Market News
From Benzinga
FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease
Tickers ANVS
Tags Parkinson’s Disease Market News Trading Ideas
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tickers ABEO ALRN ANVS ATHE
Tags DARE ABEO Market News
From Benzinga
Annovis Bio on Its Positive Results in Alzheimer's and Parkinson's Clinical Trials
Tickers ANVS BIIB
Tags ANVS News annovis Bio
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ACRX ANVS BLPH CWBR
Tags CWBR Movers LIXT
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
Tickers ADPT AFIB ANVS ATHX
Tags EBS ONCS General
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Tickers ACHV ACIU AEMD AGEN
Tags VCEL DRNA CNCE
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Tickers ABUS ACAD ACIU ADAP
Tags LGND ANVS Biotech
From Benzinga
92 Biggest Movers From Friday
Tickers AAOI ABNB ADGI ADTX
Tags ALZN RDBX GT
From Benzinga
44 Biggest Movers From Yesterday
Tickers ALF AMN ANVS AZYO
Tags CETX AZYO CSCW
From Benzinga
3 Stocks Insiders Are Buying
Tickers ANVS LSCC LTH
Tags Insider Trades Information Technology Benzinga
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
Tickers ANVS
Tags News Exclusives Health Care
From Benzinga
Here's How You Handle a Volatile Stock Like Cassava Sciences
Tickers ANVS INMB SAVA
Tags Market News ANVS INMB
From Motley Fool
Insiders Like Cassava Sciences, Which Might Be Good News
Tickers ANVS SAVA
Tags Market News NASDAQ:SAVA,NYSEAMERICAN:ANVS ANVS
From InvestorPlace
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Tickers ABBV ALZN AMRX ANVS
Tags RNXT MDXG AMRX
From Benzinga
Better Biotech Stock: Cassava Sciences vs. Annovis Bio
Tickers ANVS BIIB SAVA
Tags Market News ANVS BIIB
From Motley Fool
Tread Carefully Before Pulling the Trigger on Cassava Sciences
Tickers ANVS SAVA
Tags NASDAQ:SAVA,NYSEAMERICAN:ANVS Market News Hot Stocks
From InvestorPlace
Why Might Cassava Succeed With Its Alzheimer's Drug, When So Many Have Failed?
Tickers ANVS BIIB SAVA
Tags Market News SAVA BIIB
From Motley Fool
Why Is Biogen Pursuing a New Direction in Alzheimer's Research?
Tickers ANVS AVXL BIIB SAVA
Tags Market News AVXL ANVS
From Motley Fool
Use Weakness in these 3 Alzheimer’s Disease Stocks as Opportunity
Tickers ANVS AVXL SAVA
Tags Market News NASDAQ:SAVA,NASDAQ:AVXL,NYSEAMERICAN:ANVS AVXL
From InvestorPlace
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.